GLENMARK LIFE SCIENCES LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 829.8 INR | -1.18% |
|
-2.77% | +26.28% |
| 15/05 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| 25/04 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 876.50 | 890.25 | 878.50 |
| Spread/Res. | -5.33% | -6.80% | -5.55% |
| Spread/Supp. | +2.15% | +31.00% | +14.59% |
| Support | 812.30 | 633.40 | 724.11 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- GLS Stock
- Charts Glenmark Life Sciences Limited
